NCT01663168 arm group 13f92c9ed5d2d2ec417422de7ed6678e [clinicaltrials_resource:NCT01663168/arm-group/13f92c9ed5d2d2ec417422de7ed6678e]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01663168 arm group 13f92c9ed5d2d2ec417422de7ed6678e [clinicaltrials_resource:NCT01663168/arm-group/13f92c9ed5d2d2ec417422de7ed6678e]
Bio2RDF identifier
NCT01663168/arm-group/13f92c9ed5d2d2ec417422de7ed6678e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... f92c9ed5d2d2ec417422de7ed6678e
description [clinicaltrials_vocabulary:description]
Rifabutin 150mg tablet three t ...... ion of TB treatment (24 weeks)
identifier
clinicaltrials_resource:NCT01663168/arm-group/13f92c9ed5d2d2ec417422de7ed6678e
title
NCT01663168 arm group 13f92c9ed5d2d2ec417422de7ed6678e
@en
type
label
NCT01663168 arm group 13f92c9e ...... 92c9ed5d2d2ec417422de7ed6678e]
@en